Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective studyZhichao Tian, Weitao Yao, Shuping Dong et al.|BMC Cancer|2022Cited by 19
Clinical Experience with Apatinib and Camrelizumab in Advance Clear Cell Sarcoma: A Retrospective StudyJiaqiang Wang, Weitao Yao, Shilei Gao et al.|Cancer Management and Research|2021Cited by 10
Efficacy and safety of JMT103 in patients with giant cell tumor of bone: A multicenter, single-arm, open-label, phase Ib/II study.Xiaohui Niu, Tao Li, Feng Wei et al.|Journal of Clinical Oncology|2021Cited by 4
OA09.03 Randomized, Open-Label, Phase III Study of SAF-189s Versus Crizotinib in First-Line ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)Ao Xiong, Chun Zhou, M. Wang et al.|Journal of Thoracic Oncology|2024Cited by 2